Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse.

Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse.

BACKGROUND: Duchenne muscular dystrophy (DMD) is a lethal, progressive muscle wasting disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the muscle fibers leading to the gradual depletion of skeletal muscle. There is significant evidence demonstrating that increa...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Tinsley, J, Fairclough, R, Storer, R, Wilkes, F, Potter, A, Squire, SE, Powell, D, Cozzoli, A, Capogrosso, R, Lambert, A, Wilson, F, Wren, S, De Luca, A, Davies, K
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	Public Library of Science 2011

Gelijkaardige items

Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse.
door: Jonathon M Tinsley, et al.
Gepubliceerd in: (2011-05-01)

Future clinical and biomarker development for SMTC1100, the first utrophin modulator to enter clinical trials for Duchenne Muscular Dystrophy (DMD)
door: Tinsley, J, et al.
Gepubliceerd in: (2013)

Up-regulation of utrophin alleviates the dystrophic phenotype in the mdx mouse heart
door: Sang, E, et al.
Gepubliceerd in: (2000)

Non-toxic ubiquitous overexpression of utrophin in the mdx mouse.
door: Fisher, R, et al.
Gepubliceerd in: (2000)

Non-toxic ubiquitous over-expression of utrophin in the mdx mouse.
door: Fisher, R, et al.
Gepubliceerd in: (2001)

Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system.
door: Squire, S, et al.
Gepubliceerd in: (2002)

Chronic Dosing with Membrane Sealant Poloxamer 188 NF Improves Respiratory Dysfunction in Dystrophic Mdx and Mdx/Utrophin-/- Mice.
door: Bruce E Markham, et al.
Gepubliceerd in: (2015-01-01)

Evaluation of novel compounds for upregulation of utrophin in animal models of Duchenne muscular dystrophy therapy
door: Fairclough, R, et al.
Gepubliceerd in: (2008)

Utrophin in the therapy of Duchenne Muscular Dystrophy
door: Potter, A, et al.
Gepubliceerd in: (2006)

Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene.
door: Wakefield, P, et al.
Gepubliceerd in: (2000)

Utrophin upregulation in DMD therapy: current status and new tools for the future
door: Fairclough, R, et al.
Gepubliceerd in: (2011)

Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle
door: Kennedy, T, et al.
Gepubliceerd in: (2017)

Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle
door: Tahnee L. Kennedy, et al.
Gepubliceerd in: (2017-10-01)

Identification of new chemical compounds with upregulate utrophin for the therapy of Duchenne muscular dystrophy
door: Fairclough, R, et al.
Gepubliceerd in: (2012)

Muscle structure influences utrophin expression in mdx mice.
door: Glen B Banks, et al.
Gepubliceerd in: (2014-06-01)

A-utrophin up-regulation in mdx skeletal muscle is independent of regeneration.
door: Weir, A, et al.
Gepubliceerd in: (2004)

Erythropoietin reduces the expression of myostatin in mdx dystrophic mice
door: D. Feder, et al.
Gepubliceerd in: (2014-11-01)

Micro-utrophin improves cardiac and skeletal muscle function of severely affected D2/mdx mice
door: Kennedy, T, et al.
Gepubliceerd in: (2018)

Heregulin ameliorates the dystrophic phenotype in mdx mice.
door: Krag, T, et al.
Gepubliceerd in: (2004)

Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping.
door: Goyenvalle, A, et al.
Gepubliceerd in: (2010)

Discovery of 2-arylbenzoxazoles as upregulators of utrophin production for the treatment of Duchenne muscular dystrophy.
door: Chancellor, DR, et al.
Gepubliceerd in: (2011)

Utrophin luciferase knock-in mouse model for in vivo assessment of drug efficacy in preclinical trials for utrophin upregulation
door: Fairclough, R, et al.
Gepubliceerd in: (2010)

Characterisation of utrophin modulator SMT C1100 as a non-competitive inhibitor of firefly luciferase
door: Wilkinson, I, et al.
Gepubliceerd in: (2019)

T-cell-dependent fibrosis in the mdx dystrophic mouse.
door: Morrison, J, et al.
Gepubliceerd in: (2000)

Decrease in prosaposin in the Dystrophic mdx mouse brain.
door: Hui-Ling Gao, et al.
Gepubliceerd in: (2013-01-01)

Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer.
door: Cerletti, M, et al.
Gepubliceerd in: (2003)

A- and B-utrophin have different expression patterns and are differentially up-regulated in mdx muscle.
door: Weir, A, et al.
Gepubliceerd in: (2002)

Cardioprotective Effect of Whole Body Periodic Acceleration in Dystrophic Phenotype mdx Rodent
door: Arkady Uryash, et al.
Gepubliceerd in: (2021-05-01)

l-arginine improves dystrophic phenotype in mdx mice
door: Vincent Voisin, et al.
Gepubliceerd in: (2005-10-01)

Safety, tolerability, and pharmacokinetics of SMT C1100, a 2‐arylbenzoxazole utrophin modulator, following single‐ and multiple‐dose administration to healthy male adult volunteers
door: Tinsley, J, et al.
Gepubliceerd in: (2015)

Lipidomic Analyses Reveal Specific Alterations of Phosphatidylcholine in Dystrophic Mdx Muscle
door: William J. Valentine, et al.
Gepubliceerd in: (2022-01-01)

Functional improvement of dystrophic muscle by repression of utrophin: let-7c interaction.
door: Manoj K Mishra, et al.
Gepubliceerd in: (2017-01-01)

Second-generation compound for the modulation of utrophin in the therapy of DMD
door: Guiraud, S, et al.
Gepubliceerd in: (2015)

Increased susceptibility of the dystrophic mdx mouse heart to ischemic and hypoxic injuries
door: Zhang, W, et al.
Gepubliceerd in: (2005)

Metabolic remodeling of dystrophic skeletal muscle reveals biological roles for dystrophin and utrophin in adaptation and plasticity
door: Justin P. Hardee, et al.
Gepubliceerd in: (2021-03-01)

Mutation types and aging differently affect revertant fiber expansion in dystrophic mdx and mdx52 mice.
door: Yusuke Echigoya, et al.
Gepubliceerd in: (2013-01-01)

Dystrophic phenotype improvement in the diaphragm muscle of mdx mice by diacerhein.
door: Rafael Dias Mâncio, et al.
Gepubliceerd in: (2017-01-01)

Proteome Profiling of the Dystrophic <i>mdx</i> Mice Diaphragm
door: Olga Mucha, et al.
Gepubliceerd in: (2023-11-01)

Choline administration attenuates aspects of the dystrophic pathology in mdx mice
door: Francesca M. Alves, et al.
Gepubliceerd in: (2019-04-01)

Dysfunctional muscle and liver glycogen metabolism in mdx dystrophic mice.
door: David I Stapleton, et al.
Gepubliceerd in: (2014-01-01)